Chembio Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chembio Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chembio Diagnostics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.051.009.19
Details
Intrinsic
Valuation
LowReal ValueHigh
0.040.909.08
Details
Naive
Forecast
LowNext ValueHigh
0.0248261.249.43
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-1.04-1.04-1.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chembio Diagnostics. Your research has to be compared to or analyzed against Chembio Diagnostics' peers to derive any actionable benefits. When done correctly, Chembio Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chembio Diagnostics.

Chembio Diagnostics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Chembio Diagnostics and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Chembio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Chembio Diagnostics does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Chembio Diagnostics Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Chembio Diagnostics stock performing well and Chembio Diagnostics company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Chembio Diagnostics' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
A 1.90  0.17  0.07  0.07  2.24  0.06 (2.06)  4.22 (3.29)  8.98 
VRM 7.30  1.25  0.15  0.51  7.07  0.12 (8.85)  18.49 (10.06)  52.59 
LZB 2.05  0.17  0.07  0.10  2.33  0.06 (2.37)  3.67 (4.47)  13.54 
RIOT 6.05  0.02  0.00 (0.05)  0.00 (0.0153)  0.00  11.85 (10.06)  27.36 
BBBY 6.45  0.21  0.02  0.03  7.28  0.0133 (7.42)  14.71 (9.94)  33.75 
RDBX 12.84  0.66  0.05  0.53  13.06  0.0354 (16.89)  35.76 (18.73)  96.48 
BB 3.31  0.38  0.07  0.12  4.10  0.07 (3.13)  7.08 (6.63)  21.56 
BCS 2.18  0.14  0.05  0.05  2.39  0.0468 (2.47)  4.14 (3.86)  10.74 
T 1.13 (0.10)  0.00 (0.21)  0.00 (0.0458)  0.00  2.00 (2.45)  10.60 
MSFT 1.72  0.05  0.00 (0.02)  0.00  0.0106  0.00  2.97 (4.24)  7.83 

Cross Equities Net Income Analysis

Compare Chembio Diagnostics and related stocks such as Agilent Technologies, Vroom Inc, La-Z-Boy, Riot Blockchain, Bed Bath Beyond, Redbox Entertainment, Blackberry, Barclays Plc ADR, ATT Inc, and Microsoft Corp Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
AB1.2 B734 M549 M401 M462 M684 M316 M1.1 B719 M719 M647.1 M639.6 M
LZB106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M150 M126.8 M
RIOT(13.3 M)(10.2 M)(9.2 M)(12.1 M)(10.4 M)(8.8 M)(4.3 M)(19.8 M)(58 M)(20 M)(12.7 M)(7.9 M)(8.6 M)
BBBYBBBB(137.2 M)(137.2 M)(137.2 M)(137.2 M)(137.2 M)(559.6 M)(559.6 M)(559.6 M)(617.6 M)
BB(5.9 B)(5.9 B)(5.9 B)(5.9 B)(304 M)(1.2 B)(1.2 B)405 M93 M(1.1 B)(1.1 B)12 M(73.7 M)
BCS2.9 B2.9 B(624 M)540 M(174 M)(394 M)1.6 B(1.9 B)1.6 B2.5 B1.5 B6.2 B6.7 B
T19.9 B3.9 B7.3 B18.2 B6.2 B13.3 B13 B29.4 B19.4 B13.9 B(5.2 B)20.1 B16.2 B
MSFT17 B17 B21.9 B22.1 B12.2 B20.5 B25.5 B16.6 B39.2 B44.3 B61.3 B72.7 B78.5 B

Chembio Diagnostics and related stocks such as Agilent Technologies, Vroom Inc, La-Z-Boy, Riot Blockchain, Bed Bath Beyond, Redbox Entertainment, Blackberry, Barclays Plc ADR, ATT Inc, and Microsoft Corp Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Chembio Diagnostics financial statement analysis. It represents the amount of money remaining after all of Chembio Diagnostics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Chembio Diagnostics Competitive Analysis

The better you understand Chembio Diagnostics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Chembio Diagnostics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Chembio Diagnostics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CEMIAVRMLZBRIOTBBBYRDBXBBBCST
 6.36 
 1.03 
Chembio
 0.82 
 132.52 
Agilent
 6.03 
 2.46 
Vroom
 1.97 
 28.94 
La Z
 5.32 
 8.71 
Riot Blockchain
 39.83 
 11.41 
Bed Bath
 18.73 
 4.08 
Redbox
 2.22 
 6.90 
Blackberry
 0.49 
 8.13 
Barclays
 1.91 
 18.00 
ATT
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Chembio Diagnostics Competition Performance Charts

Complement your Chembio Diagnostics position

In addition to having Chembio Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch
Continue to Chembio Diagnostics Correlation with its peers. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
33.2 M
Quarterly Revenue Growth YOY
1.16
Return On Assets
-0.26
Return On Equity
-1.53
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CEMI
 Stock
  

USD 1.03  0.07  6.36%   

Chembio Diagnostics competes with Agilent Technologies, Vroom, La Z, Riot Blockchain, and Bed Bath; as well as few others. The company conducts business under Healthcare sector and is part of Diagnostics & Research industry. Analyzing Chembio Diagnostics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Chembio Diagnostics to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Chembio Diagnostics competition on your existing holdings. Continue to Chembio Diagnostics Correlation with its peers.
  
The current Return on Investment is estimated to decrease to -64.08. The current Return on Average Assets is estimated to decrease to -0.53. Chembio Diagnostics Revenue to Assets are most likely to slightly decrease in the upcoming years. The last year's value of Revenue to Assets was reported at 0.65. The current Asset Turnover is estimated to increase to 0.84, while Total Assets are projected to decrease to roughly 58.3 M.